Core Viewpoint - ESGold Corp. has announced a brokered private placement offering to raise gross proceeds of up to C$5 million through the sale of units priced at C$0.75 each [1][2]. Group 1: Offering Details - The offering consists of up to 6,666,667 units, each unit comprising one common share and one warrant [1][2]. - Each warrant allows the holder to purchase one common share at a price of C$1.10 within 36 months following the closing date [2]. - The company has granted the agent an option to sell an additional 1,000,000 units for up to C$750,000 in gross proceeds [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for advancing the Montauban Project in Québec and for general working capital and corporate purposes [4]. Group 3: Regulatory Compliance - The offering will comply with applicable regulatory requirements and will be available to purchasers in specific Canadian provinces, the United States, and offshore jurisdictions [5]. - The securities issued will be freely tradeable in Canada if sold to Canadian residents, without a hold period [5]. Group 4: Closing and Conditions - The offering is scheduled to close on September 18, 2025, subject to necessary regulatory approvals, including that of the Canadian Securities Exchange [7]. Group 5: Company Overview - ESGold Corp. is a pre-production resource company focused on clean mining and exploration, with its flagship Montauban property located 80 kilometers west of Quebec City [10].

Core Viewpoint - IMPACT Silver Corp. has announced an increase in its bought deal private placement from approximately C$8 million to C$13 million due to strong investor demand [1] Group 1: Offering Details - The upsized offering will consist of 36,111,112 units priced at C$0.36 per unit, each unit comprising one common share and one warrant [1][2] - Each warrant allows the holder to purchase one common share at a price of C$0.45 within 24 months after the closing date [2] - An over-allotment option allows underwriters to purchase an additional 8,333,334 units for gross proceeds of up to approximately C$3 million [3] Group 2: Use of Proceeds - The net proceeds from the offering will be used for advancing underground development and infrastructure at the Guadalupe mine, increasing processing plant throughput, expanding mining operations at the Plomosas mine, and general working capital [7] Group 3: Regulatory and Closing Information - The offering is set to close on September 17, 2025, subject to necessary approvals, including from the TSX Venture Exchange [9] - The units will be offered to purchasers in all Canadian provinces except Québec and may also be sold in offshore jurisdictions [5]

Core Viewpoint - IMPACT Silver Corp. has announced a bought deal private placement to raise approximately C$8 million through the sale of 22,222,222 units at C$0.36 per unit, with each unit consisting of one common share and one warrant [1][2]. Group 1: Offering Details - The offering price is set at C$0.36 per unit, with gross proceeds expected to be around C$8 million [1]. - Each warrant allows the holder to purchase one common share at C$0.45 within 24 months after the closing date [2]. - An over-allotment option allows underwriters to purchase an additional 5,555,556 units for up to C$2 million in gross proceeds [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for advancing underground development and infrastructure at the Guadalupe mine, increasing processing plant throughput, and expanding mining operations at the Plomosas mine [7]. - Additional funds will be allocated for general working capital and corporate purposes [7]. Group 3: Regulatory and Closing Information - The offering is subject to regulatory compliance and is scheduled to close on September 17, 2025, pending necessary approvals [9]. - Units will be offered to purchasers in all Canadian provinces except Québec and may also be sold in offshore jurisdictions [5].

Core Viewpoint - Panoro Minerals Ltd. has canceled its previously announced C$10,000,000 brokered private placement due to unfavorable market conditions and is exploring alternative financing options [1][2]. Group 1: Financing and Project Development - The net proceeds from the canceled LIFE Offering were intended for infill drilling, metallurgical testing, pre-feasibility engineering, and an updated preliminary economic assessment (PEA) for the Cotabambas Project [1]. - The company is in advanced discussions regarding alternative financing options, including the receipt of a third payment from the sale of the Antilla Project and the sale of a non-core exploration project [2]. - The Cotabambas Project contains an estimated 3.3 million ounces of gold in the indicated category and 2.7 million ounces in the inferred category, along with 3.8 billion pounds of copper in the indicated category and 3.0 billion pounds in the inferred category [2]. Group 2: Market Conditions and Project Valuation - The updated PEA will incorporate current gold prices exceeding $3,400 per ounce and copper prices over $4.40 per pound, which are expected to significantly enhance the value of the Cotabambas Project [2]. - The company anticipates receiving a third payment from the Antilla Project sale in 2025, along with a contingent payment based on the estimated NPV of the project [4]. Group 3: Strategic Alternatives and Corporate Focus - Panoro is evaluating potential strategic alternatives with various parties to advance the Cotabambas Project towards construction and operation [5]. - The company remains focused on completing its technical objectives, including project optimization studies that will contribute to the PEA and define the scope for the prefeasibility study for the Cotabambas Project [3].

Core Viewpoint - MustGrow Biologics Corp. has successfully closed a non-brokered private placement, raising approximately $2.1 million through the sale of units, along with a repricing of warrants and a shares for debt settlement agreement [1][3][11] Group 1: LIFE Offering - The LIFE Offering consisted of 3,059,731 units sold at a price of $0.70 per unit, generating gross proceeds of approximately $2,141,812 [1] - Each unit includes one common share and one common share purchase warrant, with warrants exercisable for 60 months at an exercise price of $0.90 per share [2] - The net proceeds will be used for inventory production of the mustard-derived organic biofertility product TerraSanteTM, inventory for agricultural products, and general corporate purposes [3] Group 2: Warrant Repricing - The company has repriced 1,721,610 outstanding warrants from a previous private placement, reducing the exercise price from $1.90 to $0.90 per share [7][8] - The repriced warrants include an acceleration provision that allows for an earlier expiry if the share price exceeds $1.08 for ten consecutive trading days [9] - This repricing is pending final approval from the TSX Venture Exchange [10] Group 3: Shares for Debt Settlement - MustGrow is settling approximately $2,385,000 in outstanding principal under unsecured convertible debentures by issuing up to 3,407,134 shares at a deemed price of $0.70 per share [11] - The settlement also includes a cash payment for all accrued and unpaid interest [11] - The shares issued in this settlement will be subject to a statutory hold period of four months and one day [12] Group 4: Insider Participation and Compliance - Certain insiders participated in the LIFE Offering, purchasing a total of 285,716 units, which will be subject to a four-month hold period [13] - The participation of insiders in the LIFE Offering and other transactions is considered a related party transaction under Multilateral Instrument 61-101 [14] - The company is relying on exemptions from formal valuation and minority shareholder approval requirements due to the transaction's market capitalization not exceeding 25% [14] Group 5: Company Overview - MustGrow Biologics Corp. provides innovative biological and regenerative agriculture solutions, focusing on eco-friendly alternatives to synthetic chemicals and fertilizers [15] - The company has a portfolio of approximately 109 patents and collaborates with agriculture companies like Bayer AG for commercialization [15] - MustGrow is publicly traded on the TSX Venture Exchange with approximately 58.9 million common shares outstanding [16]

Core Viewpoint - Silver47 Exploration Corp. has announced an increase in its brokered private placement offering to up to 28,572,000 units at a price of $0.70 per unit, aiming for gross proceeds of up to $20,000,400 due to strong investor demand [1][2]. Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, with each whole warrant exercisable at $1.00 per share for 36 months [2]. - The company has granted the agents an option to increase the offering size by up to $3,000,060, potentially raising total gross proceeds to $23,000,460 if fully exercised [3]. Regulatory Compliance - The offering is being conducted in compliance with National Instrument 45-106, allowing sales to purchasers in all Canadian provinces except Quebec, under the "listed issuer financing exemption" [4]. Use of Proceeds - The net proceeds from the offering will be utilized for further exploration work on the company's projects and for general working capital purposes [2]. Closing Timeline - The company expects to close the offering around September 16, 2025, subject to regulatory approvals and the approval of the TSX Venture Exchange [6]. Agent Compensation - The company will pay the agents a cash commission of 6% of the gross proceeds and issue broker warrants exercisable for 36 months, equal to 6% of the units sold [7]. Company Overview - Silver47 Exploration Corp. focuses on developing silver-rich deposits in North America, with a combined resource totaling 236 million ounces of silver equivalent at an average grade of 334 g/t AgEq inferred and 10 million ounces at 333 g/t AgEq indicated [9].

Core Viewpoint - Silver47 Exploration Corp. has announced a brokered private placement to raise up to $14 million through the sale of units priced at $0.70 each, with the offering expected to close around September 16, 2025 [1][6]. Group 1: Offering Details - The offering consists of up to 20,000,000 units, each unit comprising one common share and one-half of a common share purchase warrant, with each whole warrant exercisable at $1.00 for 36 months [1][2]. - The company has granted agents an option to increase the offering size by up to $2.1 million [3]. - The offering is available to purchasers in all Canadian provinces except Quebec, relying on the "listed issuer financing exemption" [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for further exploration work on the company's projects and for general working capital purposes [2]. Group 3: Financial Terms - The company will pay agents a cash commission of 6% of the gross proceeds and issue broker warrants equal to 6% of the units sold, exercisable at $0.70 for 36 months [7]. Group 4: Company Overview - Silver47 Exploration Corp. focuses on developing silver-rich deposits in North America, with a combined resource totaling 236 million ounces of silver equivalent at an inferred grade of 334 g/t and 10 million ounces at an indicated grade of 333 g/t [9]. - The company operates in Alaska, Nevada, and New Mexico, which are known for their prolific mining jurisdictions [9].

Core Viewpoint - Tier One Silver Inc. has announced that its proposed private placement equity financing will not proceed, and the company will return any advanced funds to participating subscribers and their brokers [1]. Group 1: Financing and Future Plans - The company is actively seeking alternative financing options and will make an announcement once arrangements are made [2]. - The private placement was offered under a listed issuer financing exemption (LIFE) and was initially filed on June 23, 2025 [1]. Group 2: Company Overview - Tier One Silver is an exploration company focused on discovering valuable silver, gold, and copper deposits in Peru, with a primary focus on its flagship project, Curibaya [3]. - The management and technical teams of the company have a strong track record in capital raising, discovery, and monetization of exploration success [3].

Core Points - Terra Balcanica Resources Corp. has successfully closed the second and final tranche of its private placement, raising gross proceeds of C$302,581 through the issuance of 3,025,809 units at a price of C$0.10 per unit, bringing the total offering amount to C$1,117,495 [1][2][3] Financing Details - Each unit consists of one common share and one-half of a common share purchase warrant, with each whole warrant exercisable at C$0.20 for a period of 24 months from the closing date [1] - The initial tranche of the offering was closed on July 11, 2025, raising C$814,914 through the issuance of 8,149,141 units [1] - Finders' fees of C$7,000 were paid, and 70,000 non-transferable finder's warrants were issued, also exercisable at C$0.20 for 24 months [1][2] Insider Participation - Kim Oishi, a director of the company, purchased 25,809 units in the final tranche, which is classified as a related party transaction [2] - The participation of the insider was approved by independent directors, and it does not materially change the percentage of outstanding securities owned by the insider [2] Regulatory Compliance - The private placement was conducted under the listed issuer financing exemption, and the securities issued are not subject to a hold period under Canadian securities laws [3] - However, the finder's warrants and the common shares issuable upon their exercise are subject to a hold period expiring on December 14, 2025 [3] Company Overview - Terra Balcanica is focused on polymetallic and energy metals exploration, targeting large-scale mineral systems in the Balkans and northern Saskatchewan, Canada [5] - The company holds a 90% interest in the Viogor-Zanik Project in Bosnia and has a 100% optioned portfolio of uranium-prospective licenses in Canada [5] - The company emphasizes responsible engagement with local communities and is committed to sustainable practices [5]

Core Insights - Ethos has partnered with Lifeforce to provide policyholders access to a comprehensive health optimization platform, which includes biomarker testing, longevity protocols, and health coaching [1][2][3] - The collaboration aims to combine financial protection with health optimization, allowing families to safeguard both their financial future and healthspan [1][3][4] Company Overview - Ethos is a leading life insurance technology company focused on democratizing access to life insurance and enhancing the purchasing experience through a fully digital application process [4][6] - Lifeforce is recognized as the largest longevity medicine platform, offering services such as at-home biomarker testing and access to expert physicians, with a significant number of members reporting health improvements [7] Partnership Details - The partnership provides Ethos policyholders with a $250 benefit towards Lifeforce's Diagnostic offering, which includes personalized treatment protocols and ongoing health coaching [1][2] - Ethos is enhancing its perks program to address policyholders' priorities, complementing its Indexed Universal Life insurance offering and estate planning tools [3][5] Industry Impact - The collaboration is expected to improve accessibility and affordability of life insurance and estate planning for millions of families, supported by industry-leading carriers [5]